Dr. Zuoyu Xu (USA)
Zuoyu Xu, Ph.D., Program Officer, Bacteriology and Mycology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), USA (2007– present). Dr. Xu graduated from Fudan University, Shanghai, with his B.S. in Microbiology (1982), M.S. in Virology (1985), and subsequently became faculty at the Department of Biology, Fudan University (1985). Dr. Xu went to the United States in 1989, studied the function of molecular chaperones in regulating protein synthesis, and earned his Ph.D. degree in 1992. Dr. Xu conducted postdoctoral research in organelle inheritance and vesicle trafficking and joined the faculty at Dartmouth Medical School, Dartmouth College in 1997. Prior to working at the NIH, Dr. Xu was at the Centre for Research, Pfizer (1998-2007) where he led exploratory research on antimicrobial resistance and antibacterial drug discovery. At the NIH, Dr. Xu leads initiatives combating antimicrobial resistance, and directs new antibacterial discovery and development.
Zuoyu Xu, Ph.D., Program Officer, Bacteriology and Mycology, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), USA (2007– present). Dr. Xu graduated from Fudan University, Shanghai, with his B.S. in Microbiology (1982), M.S. in Virology (1985), and subsequently became faculty at the Department of Biology, Fudan University (1985). Dr. Xu went to the United States in 1989, studied the function of molecular chaperones in regulating protein synthesis, and earned his Ph.D. degree in 1992. Dr. Xu conducted postdoctoral research in organelle inheritance and vesicle trafficking and joined the faculty at Dartmouth Medical School, Dartmouth College in 1997. Prior to working at the NIH, Dr. Xu was at the Centre for Research, Pfizer (1998-2007) where he led exploratory research on antimicrobial resistance and antibacterial drug discovery. At the NIH, Dr. Xu leads initiatives combating antimicrobial resistance, and directs new antibacterial discovery and development.